Cricopharyngeal Botox injection: indications and technique.
Mieke B J Moerman
https://pubmed.ncbi.nlm.nih.gov/17099352/Actively Recruiting
Led by All India Institute of Medical Sciences · Updated on 2026-07-07
100
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to evaluate the use of Botulinum toxin injections in treating pharyngo-esophageal dysphagia caused by dysfunction of the cricopharyngeus muscle. This condition often affects patients with neurological disorders such as stroke, multiple sclerosis, parkinsonism, or dystonia, leading to difficulties in swallowing due to abnormal muscle tone. Currently, there is insufficient evidence from randomized controlled trials to confirm the safety and effectiveness of this treatment. Participants will receive either 50 units of Botulinum toxin A Botox or a placebo injected into the cricopharyngeus muscle under endoscopic guidance while under general anesthesia. The procedure involves injection into four quadrants of the muscle and is performed with an esophago-gastro-duodenoscope. A Ryles tube will be placed before the procedure and kept for one day after. Patients will be observed for adverse events post-procedure. The study is randomized, placebo-controlled, and quadruple-blinded. During the trial, participants will undergo clinical swallowing assessments, video fluoroscopy, flexible endoscopic evaluation, and esophageal manometry before and after treatment. Researchers will measure swallowing function improvements at 3 weeks and 3 months, along with monitoring for any adverse effects. The study duration includes follow-up visits and assessments up to 3 months post-injection to evaluate treatment outcomes and safety.
CONDITIONS
Onabotulinum Toxin A (Botox) in the Treatment of Pharyngo-esophageal Dysphagia
A
Arunmozhimaran Elavarasi, MD DM
P
Pramod Garg, MD DM
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
All India Institute of Medical Sciences
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single procedure visit
Participants receive an injection of either Botulinum toxin (Botox) or placebo into the cricopharyngeus muscle under general anesthesia using endoscopic guidance. A feeding tube is placed before the procedure and kept for one day after. Participants are monitored for adverse events after the procedure.
1 visit (in-person)
Duration - 3 months
Participants undergo clinical and instrumental swallowing assessments including video fluoroscopy, flexible endoscopy, and esophageal manometry to evaluate swallowing improvements and monitor safety.
Multiple visits during follow-up
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Mieke B J Moerman
https://pubmed.ncbi.nlm.nih.gov/17099352/Julie Regan, Anne Murphy, Mindy Chiang...
https://pubmed.ncbi.nlm.nih.gov/24801118/Mahesh S Parameswaran, Ahmed M S Soliman
https://pubmed.ncbi.nlm.nih.gov/12389853/Priyanka Samal, Vinay Goyal, Govind K Makharia...
https://pubmed.ncbi.nlm.nih.gov/30304925/Maggie A Kuhn, Peter C Belafsky
https://pubmed.ncbi.nlm.nih.gov/24262961/Jacqui Allen, Cheryl J White, Rebecca Leonard...
https://pubmed.ncbi.nlm.nih.gov/20665853/G N Ali, K L Wallace, T M Laundl...
https://pubmed.ncbi.nlm.nih.gov/9190098/Giovanni Zaninotto, Rosario Marchese Ragona, Chiara Briani...
https://pubmed.ncbi.nlm.nih.gov/15585387/Elizabeth A Kelly, Ian J Koszewski, Safwan S Jaradeh...
https://pubmed.ncbi.nlm.nih.gov/23534124/Rosa Terre, Margarida Valles, Agusti Panades...
https://pubmed.ncbi.nlm.nih.gov/18649151/All India Institute of Medical Sciences
Lead Sponsor